カルサルシン-1は,アンジオテンシンII誘発性心筋縮から保護する
Derk Frank1, Christian Kuhn, Martin van Eickels
1Department of Internal Medicine III, University of Heidelberg, Germany.
Circulation
|November 21, 2007
まとめ
心臓におけるカルサルシン-1 (CS1) の過剰発現は,カルシヌーリンのシグナル伝達を阻害することによって,病的な心筋縮を予防します. これは,CS1が心臓病の潜在的な治療標的であることを示唆しています.
科学分野:
- 心血管生物学 心血管生物学
- 分子心臓病学 分子心臓病学
- Z-ディスクタンパク質
背景:
- カルサルシン-1 (CS1) 欠乏症は,カルシヌーリンのシグナル伝達と病理学的高縮に心臓を敏感にします.
- 以前の研究では,CS1が心臓機能における役割を確立しました.
研究 の 目的:
- カルサルシン-1 (CS1) の過剰発現による潜在的な抗ハイパートロフィック効果を調査する.
- CS1が病理性心筋縮を阻害するという仮説を in vitro と in vivo で検証する.
主な方法:
- 新生児の心筋細胞にCS1のアデノウイルスの遺伝子転送.
- CS1過剰発現するトランスジェニックマウスの生成 (CS1Tg).
- Gqアゴニスト (Ang-II,エンドセリン-1,フェニルエフリン) の刺激とマウスの長期的なAng-II注入.
主要な成果:
- CS1過剰発現は,Gq-アゴニスト誘発の心筋細胞高縮を阻害し,高縮遺伝子マーカー (ANF,MCIP1.4) を減少させた.
- CS1Tgマウスは,刺激なしでは病理的フェノタイプを示さなかった.
- Ang-II注入は,CS1Tgマウスでは高血圧を引き起こしたが,心筋縮は起こさなかったので,心臓の機能を保ち,縮遺伝子の誘導を鈍化した.
結論:
- サルコメリックタンパク質CS1は,カルシヌーリンのシグナル伝達を阻害することで,Ang-II誘発の心筋細胞高縮を予防します.
- CS1の過剰発現は,病理性心筋縮を弱めるための新たな治療戦略を提示する可能性がある.
関連する概念動画
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:16Calmodulin-dependent Signaling
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...